FR1560264A - - Google Patents

Info

Publication number
FR1560264A
FR1560264A FR1560264DA FR1560264A FR 1560264 A FR1560264 A FR 1560264A FR 1560264D A FR1560264D A FR 1560264DA FR 1560264 A FR1560264 A FR 1560264A
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Application granted granted Critical
Publication of FR1560264A publication Critical patent/FR1560264A/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/235—Adenoviridae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR1560264D 1966-08-31 1967-08-30 Expired FR1560264A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US57624766A 1966-08-31 1966-08-31

Publications (1)

Publication Number Publication Date
FR1560264A true FR1560264A (fr) 1969-03-21

Family

ID=24303574

Family Applications (2)

Application Number Title Priority Date Filing Date
FR1560264D Expired FR1560264A (fr) 1966-08-31 1967-08-30
FR119482A Expired FR7233M (fr) 1966-08-31 1967-08-30

Family Applications After (1)

Application Number Title Priority Date Filing Date
FR119482A Expired FR7233M (fr) 1966-08-31 1967-08-30

Country Status (5)

Country Link
US (1) US3458621A (fr)
JP (1) JPS526337B1 (fr)
DE (1) DE1617300C3 (fr)
FR (2) FR1560264A (fr)
GB (1) GB1125210A (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2197576A1 (fr) * 1972-08-30 1974-03-29 Univ Illinois
EP0009577A1 (fr) * 1978-08-18 1980-04-16 Burns-Biotec Laboratories Inc. Préparation d'un vaccin oral et méthode pour augmenter la résistance des porcs contre la dysentérie porcine

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2103519C3 (de) * 1971-01-26 1975-11-06 Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung E.V., 8000 Muenchen Impfstoffzubereitung zur oralen Pocken-Impfung
US4152413A (en) * 1978-08-18 1979-05-01 Chromalloy American Corporation Oral vaccine for swine dysentery and method of use
US4152415A (en) * 1978-08-18 1979-05-01 Iowa State University Research Foundation, Inc. Method of increasing the effectiveness of oral vaccination for swine dysentery
US4152414A (en) * 1978-08-18 1979-05-01 Iowa State University Research Foundation, Inc. Combination vaccine for swine dysentery and method of use
DK0603992T4 (da) * 1992-12-22 2001-03-05 Univ Cincinnati Oral indgivelse af immunologisk aktive biomolekyler og andre terapeutiske proteiner
IL148247A0 (en) 1999-08-24 2002-09-12 Teva Pharma A vaccine composition and method of using the same
US6592869B2 (en) 1999-08-24 2003-07-15 Teva Pharmaceutical Industries, Ltd. Vaccine composition and method of using the same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3317393A (en) * 1964-06-08 1967-05-02 Robert M Chanock Immunization by selective infection of the intestinal tract with an encapsulated live virus

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2197576A1 (fr) * 1972-08-30 1974-03-29 Univ Illinois
EP0009577A1 (fr) * 1978-08-18 1980-04-16 Burns-Biotec Laboratories Inc. Préparation d'un vaccin oral et méthode pour augmenter la résistance des porcs contre la dysentérie porcine

Also Published As

Publication number Publication date
FR7233M (fr) 1969-09-01
DE1617300C3 (de) 1979-07-05
GB1125210A (en) 1968-08-28
DE1617300B2 (de) 1978-11-09
US3458621A (en) 1969-07-29
DE1617300A1 (de) 1971-02-25
JPS526337B1 (fr) 1977-02-21

Similar Documents

Publication Publication Date Title
FR1560264A (fr)
AT281852B (fr)
AU5917865A (fr)
AU428063B2 (fr)
AU424443B2 (fr)
AU433222B2 (fr)
AU414526B2 (fr)
AU421822B2 (fr)
AU417216B2 (fr)
AU415165B1 (fr)
AU218666A (fr)
AU1144366A (fr)
AU6703465A (fr)
AU612166A (fr)
AU5895065A (fr)
AU1111066A (fr)
AU855865A (fr)
BE475118A (fr)
AU1027866A (fr)
AU433620A (fr)
AU415780B2 (fr)
BE692900A (fr)
AU2390066A (fr)
AU407778B2 (fr)
AU414093B2 (fr)